Other search tools

About this data

The publication data currently available has been vetted by Vanderbilt faculty, staff, administrators and trainees. The data itself is retrieved directly from NCBI's PubMed and is automatically updated on a weekly basis to ensure accuracy and completeness.

If you have any questions or comments, please contact us.

Results: 1 to 10 of 14

Publication Record

Connections

Does chemotherapy prevent HCV-related hepatocellular carcinoma? Pros.
Masuzaki R, Yoshida H, Omata M
(2010) Dig Liver Dis 42 Suppl 3: S281-6
MeSH Terms: Antiviral Agents, Carcinoma, Hepatocellular, Chemoprevention, Hepatitis C, Chronic, Humans, Interferon alpha-2, Interferon-alpha, Liver Neoplasms, Patient Selection, Polyethylene Glycols, Primary Prevention, Recombinant Proteins, Retinoids
Added May 2, 2014
0 Communities
1 Members
0 Resources
13 MeSH Terms
Peginterferon alfa-2a and ribavirin in Latino and non-Latino whites with hepatitis C.
Rodriguez-Torres M, Jeffers LJ, Sheikh MY, Rossaro L, Ankoma-Sey V, Hamzeh FM, Martin P, Latino Study Group
(2009) N Engl J Med 360: 257-67
MeSH Terms: Adult, Alanine Transaminase, Antiviral Agents, Drug Therapy, Combination, European Continental Ancestry Group, Female, Genotype, Hepacivirus, Hepatitis C, Chronic, Hispanic Americans, Humans, Interferon alpha-2, Interferon-alpha, Liver, Logistic Models, Male, Middle Aged, Polyethylene Glycols, Prospective Studies, Recombinant Proteins, Recurrence, Ribavirin, Viral Load, Young Adult
Added May 20, 2016
0 Communities
1 Members
0 Resources
24 MeSH Terms
Phase III trial comparing concurrent biochemotherapy with cisplatin, vinblastine, dacarbazine, interleukin-2, and interferon alfa-2b with cisplatin, vinblastine, and dacarbazine alone in patients with metastatic malignant melanoma (E3695): a trial coordinated by the Eastern Cooperative Oncology Group.
Atkins MB, Hsu J, Lee S, Cohen GI, Flaherty LE, Sosman JA, Sondak VK, Kirkwood JM, Eastern Cooperative Oncology Group
(2008) J Clin Oncol 26: 5748-54
MeSH Terms: Adult, Aged, Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocols, Cyclophosphamide, Dacarbazine, Disease-Free Survival, Female, Humans, Interferon alpha-2, Interferon-alpha, Interleukin-2, Kaplan-Meier Estimate, Male, Melanoma, Middle Aged, Neoplasm Metastasis, Recombinant Proteins, Time Factors, Treatment Outcome, United States, Vincristine, Young Adult
Added March 20, 2014
0 Communities
1 Members
0 Resources
23 MeSH Terms
Phase I/II trial of outpatient PEG-interferon with interleukin-2 in advanced renal cell carcinoma: a cytokine working group study.
Clark JI, Mehrabi J, Sosman JA, Logan TF, Margolin KA, Dutcher JP, Urba WJ, Ernstoff MS, McDermott DF, Lau AM, Atkins MB
(2007) J Immunother 30: 839-46
MeSH Terms: Acute Kidney Injury, Adult, Aged, Antineoplastic Combined Chemotherapy Protocols, Carcinoma, Renal Cell, Cardiomyopathies, Dose-Response Relationship, Drug, Female, Humans, Interferon alpha-2, Interferon-alpha, Interleukin-2, Kidney Neoplasms, Male, Middle Aged, Outpatients, Polyethylene Glycols, Recombinant Proteins, Survival Analysis, Treatment Outcome
Added March 20, 2014
0 Communities
1 Members
0 Resources
20 MeSH Terms
Phase II trial of sorafenib plus interferon alfa-2b as first- or second-line therapy in patients with metastatic renal cell cancer.
Gollob JA, Rathmell WK, Richmond TM, Marino CB, Miller EK, Grigson G, Watkins C, Gu L, Peterson BL, Wright JJ
(2007) J Clin Oncol 25: 3288-95
MeSH Terms: Adult, Aged, Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocols, Benzenesulfonates, Carcinoma, Renal Cell, Female, Humans, Interferon alpha-2, Interferon-alpha, Kidney Neoplasms, Magnetic Resonance Imaging, Male, Middle Aged, Niacinamide, North Carolina, Phenylurea Compounds, Pyridines, Recombinant Proteins, Sorafenib, Tomography, X-Ray Computed, Treatment Outcome
Added October 17, 2015
0 Communities
1 Members
0 Resources
22 MeSH Terms
Randomized phase III trial of high-dose interleukin-2 versus subcutaneous interleukin-2 and interferon in patients with metastatic renal cell carcinoma.
McDermott DF, Regan MM, Clark JI, Flaherty LE, Weiss GR, Logan TF, Kirkwood JM, Gordon MS, Sosman JA, Ernstoff MS, Tretter CP, Urba WJ, Smith JW, Margolin KA, Mier JW, Gollob JA, Dutcher JP, Atkins MB
(2005) J Clin Oncol 23: 133-41
MeSH Terms: Adult, Aged, Antineoplastic Agents, Carcinoma, Renal Cell, Female, Humans, Injections, Subcutaneous, Interferon alpha-2, Interferon-alpha, Interleukin-2, Kidney Neoplasms, Male, Middle Aged, Neoplasm Metastasis, Recombinant Proteins, Survival Rate
Added March 5, 2014
0 Communities
1 Members
0 Resources
16 MeSH Terms
A phase II pilot trial of concurrent biochemotherapy with cisplatin, vinblastine, temozolomide, interleukin 2, and IFN-alpha 2B in patients with metastatic melanoma.
Atkins MB, Gollob JA, Sosman JA, McDermott DF, Tutin L, Sorokin P, Parker RA, Mier JW
(2002) Clin Cancer Res 8: 3075-81
MeSH Terms: Adult, Aged, Antineoplastic Combined Chemotherapy Protocols, Brain Neoplasms, Cisplatin, Dacarbazine, Disease-Free Survival, Female, Granulocyte Colony-Stimulating Factor, Humans, Infusions, Intravenous, Interferon alpha-2, Interferon-alpha, Interleukin-2, Male, Melanoma, Middle Aged, Pilot Projects, Recombinant Proteins, Temozolomide, Treatment Outcome, Vinblastine
Added March 5, 2014
0 Communities
1 Members
0 Resources
22 MeSH Terms
Immunomodulatory effects of high-dose and low-dose interferon alpha2b in patients with high-risk resected melanoma: the E2690 laboratory corollary of intergroup adjuvant trial E1690.
Kirkwood JM, Richards T, Zarour HM, Sosman J, Ernstoff M, Whiteside TL, Ibrahim J, Blum R, Wieand S, Mascari R
(2002) Cancer 95: 1101-12
MeSH Terms: Adult, Aged, Biomarkers, Tumor, Chemotherapy, Adjuvant, Female, HLA Antigens, Humans, Intercellular Adhesion Molecule-1, Interferon alpha-2, Interferon-alpha, Killer Cells, Natural, Male, Melanoma, Middle Aged, Phenotype, Predictive Value of Tests, Recombinant Proteins, Skin Neoplasms, T-Lymphocytes, Treatment Outcome
Added March 5, 2014
0 Communities
1 Members
0 Resources
20 MeSH Terms
A multi-institutional phase II trial of a novel inpatient schedule of continuous interleukin-2 with interferon alpha-2b in advanced renal cell carcinoma: major durable responses in a less highly selected patient population.
Clark JI, Kuzel TM, Lestingi TM, Fisher SG, Sorokin P, Martone B, Viola M, Sosman JA
(2002) Ann Oncol 13: 606-13
MeSH Terms: Adult, Aged, Antineoplastic Combined Chemotherapy Protocols, Carcinoma, Renal Cell, Drug Administration Schedule, Female, Humans, Interferon alpha-2, Interferon-alpha, Interleukin-2, Kidney Neoplasms, Male, Middle Aged, Recombinant Proteins, Survival Analysis, Treatment Outcome
Added March 5, 2014
0 Communities
1 Members
0 Resources
16 MeSH Terms
Outpatient biochemotherapy with interleukin-2 and interferon alfa-2b in patients with metastatic malignant melanoma: results of two phase II cytokine working group trials.
Flaherty LE, Atkins M, Sosman J, Weiss G, Clark JI, Margolin K, Dutcher J, Gordon MS, Lotze M, Mier J, Sorokin P, Fisher RI, Appel C, Du W
(2001) J Clin Oncol 19: 3194-202
MeSH Terms: Adult, Aged, Ambulatory Care, Antineoplastic Combined Chemotherapy Protocols, Cisplatin, Dacarbazine, Disease-Free Survival, Female, Humans, Interferon alpha-2, Interferon-alpha, Interleukin-2, Male, Melanoma, Middle Aged, Recombinant Proteins, Survival Rate
Added March 5, 2014
0 Communities
1 Members
0 Resources
17 MeSH Terms